Cargando…
Synthesis and Combinational Antibacterial Study of 5″-Modified Neomycin
A library of 5″-modified neomycin derivatives were synthesized for an antibacterial structure-activity optimization strategy. Two leads exhibited prominent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Antibacterial activities we...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783947/ https://www.ncbi.nlm.nih.gov/pubmed/19629142 http://dx.doi.org/10.1038/ja.2009.66 |
_version_ | 1782174702102380544 |
---|---|
author | Zhang, Jianjun Keller, Katherine Takemoto, Jon Y. Bensaci, Mekki Litke, Anthony Czyryca, Przemyslaw Greg Chang, Cheng-Wei Tom |
author_facet | Zhang, Jianjun Keller, Katherine Takemoto, Jon Y. Bensaci, Mekki Litke, Anthony Czyryca, Przemyslaw Greg Chang, Cheng-Wei Tom |
author_sort | Zhang, Jianjun |
collection | PubMed |
description | A library of 5″-modified neomycin derivatives were synthesized for an antibacterial structure-activity optimization strategy. Two leads exhibited prominent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Antibacterial activities were measured when combined with other clinically used antibiotics. Significant synergistic activities were observed which may lead to the development of novel therapeutic practices in the battle against infectious bacteria. |
format | Text |
id | pubmed-2783947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
record_format | MEDLINE/PubMed |
spelling | pubmed-27839472010-04-01 Synthesis and Combinational Antibacterial Study of 5″-Modified Neomycin Zhang, Jianjun Keller, Katherine Takemoto, Jon Y. Bensaci, Mekki Litke, Anthony Czyryca, Przemyslaw Greg Chang, Cheng-Wei Tom J Antibiot (Tokyo) Article A library of 5″-modified neomycin derivatives were synthesized for an antibacterial structure-activity optimization strategy. Two leads exhibited prominent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Antibacterial activities were measured when combined with other clinically used antibiotics. Significant synergistic activities were observed which may lead to the development of novel therapeutic practices in the battle against infectious bacteria. 2009-07-24 2009-10 /pmc/articles/PMC2783947/ /pubmed/19629142 http://dx.doi.org/10.1038/ja.2009.66 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Zhang, Jianjun Keller, Katherine Takemoto, Jon Y. Bensaci, Mekki Litke, Anthony Czyryca, Przemyslaw Greg Chang, Cheng-Wei Tom Synthesis and Combinational Antibacterial Study of 5″-Modified Neomycin |
title | Synthesis and Combinational Antibacterial Study of 5″-Modified Neomycin |
title_full | Synthesis and Combinational Antibacterial Study of 5″-Modified Neomycin |
title_fullStr | Synthesis and Combinational Antibacterial Study of 5″-Modified Neomycin |
title_full_unstemmed | Synthesis and Combinational Antibacterial Study of 5″-Modified Neomycin |
title_short | Synthesis and Combinational Antibacterial Study of 5″-Modified Neomycin |
title_sort | synthesis and combinational antibacterial study of 5″-modified neomycin |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783947/ https://www.ncbi.nlm.nih.gov/pubmed/19629142 http://dx.doi.org/10.1038/ja.2009.66 |
work_keys_str_mv | AT zhangjianjun synthesisandcombinationalantibacterialstudyof5modifiedneomycin AT kellerkatherine synthesisandcombinationalantibacterialstudyof5modifiedneomycin AT takemotojony synthesisandcombinationalantibacterialstudyof5modifiedneomycin AT bensacimekki synthesisandcombinationalantibacterialstudyof5modifiedneomycin AT litkeanthony synthesisandcombinationalantibacterialstudyof5modifiedneomycin AT czyrycaprzemyslawgreg synthesisandcombinationalantibacterialstudyof5modifiedneomycin AT changchengweitom synthesisandcombinationalantibacterialstudyof5modifiedneomycin |